Swiss American CDMO
Private Company
Total funding raised: $10M
Overview
Swiss American CDMO is a specialized, full-service contract organization focused on the topical dermatology and wound care markets. The company differentiates itself through deep formulation expertise, flexible development models, and an integrated manufacturing environment with significant experience in OTC drugs and topical medical devices. With a client base operating in over 190 countries and a strong track record, including building the EltaMD® brand, it positions itself as a partner for both established and emerging brands seeking to commercialize skin health products.
Technology Platform
Integrated RID laboratory and cGMP manufacturing facility for topical formulation development, optimization, and production. Capabilities include specialized compounding, flexible filling/packaging, and a state-of-the-art water purification system.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Swiss American CDMO competes in the topical CDMO space against larger, diversified CDMOs and smaller niche players. Its differentiation lies in its deep, 35+ year formulation heritage in skin/wound care, flexible development models, and integrated services from discovery to commercial packaging for complex regulatory pathways.